Related Experiment Video
Updated: May 30, 2025

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Electronic cigarettes for smoking cessation
Nicola Lindson1, Ailsa R Butler1, Hayden McRobbie2
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Electronic cigarettes (ECs) with nicotine significantly increase smoking cessation rates compared to nicotine replacement therapy (NRT) and non-nicotine ECs. While generally safe, more research is needed to fully assess long-term safety.
Area of Science:
- Public Health
- Clinical Trials
- Evidence-Based Medicine
Background:
- Electronic cigarettes (ECs) are vaping devices used to deliver nicotine.
- There is ongoing debate regarding their efficacy and safety for smoking cessation.
- This review is an update of a living systematic review on ECs for smoking abstinence.
Purpose of the Study:
- To evaluate the safety, tolerability, and effectiveness of nicotine ECs for long-term smoking abstinence.
- Comparisons include non-nicotine ECs, other smoking cessation treatments, and no treatment.
Main Methods:
- Systematic review including randomized controlled trials (RCTs) and uncontrolled intervention studies.
- Searches conducted across major databases up to February 2024.
- Risk of bias and GRADE assessments used; meta-analyses performed for pooled data.
Main Results:
- High-certainty evidence shows nicotine ECs increase quit rates versus NRT (RR 1.59).
- Moderate-certainty evidence shows nicotine ECs increase quit rates versus non-nicotine ECs (RR 1.46).
- Adverse events (AEs) rates were similar between nicotine ECs and NRT/non-nicotine ECs; low-certainty evidence suggests higher AEs versus behavioral support.
Conclusions:
- Nicotine ECs are effective for smoking cessation, with high-certainty evidence supporting their use over NRT.
- No evidence of serious harm detected, but longer-term safety requires further investigation.
- The review is ongoing, with monthly searches to incorporate new evidence.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Inhaled Medications